1-(2-(2-chlorobenzoyl)-4-chlorophenyl)-5-glycylaminomethyl-3-dimethylaminocarbonyl-1H-1,2,4-triazole hydrochloride,
450191-S,
rilmazafone,
rilmazafone hydrochloride,
S 450191,
S-450191,
rilmazafone hydrochloride,
UNII-25T258X8BV,
Rilmazafone HCl,
85815-37-8,
25T258X8BV,
CCRIS 1929,
450191-S,
450191S,
1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-, monohydrochloride, dihydrate,
Rilmazafone hydrochloride [JAN],
RilmazafoneHydrochloride,
SCHEMBL409409,
DTXSID80235095,
HY-U00228,
AN-5697,
CS-7384,
5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl-1,2,4-triazole-3-carboxamide hydrochloride,
Rhythmy,
C21H20Cl2N6O3.ClH.2H2O,
CID9958041,
CID 9958041,
C21-H20-Cl2-N6-O3.Cl-H.2H2-O,
5-((2-aminoacetamido) methyl)-1-(4-chloro-2-(o-chlorobenzoyl)phenyl)-N, N-dimethyl-1H-s-triazole-3-carboxamide hydrochloride dihydrate,
5-[(2-aminoacetamido)methyl]-1-[4-chloro-2-(o-chlorobenzoyl)phenyl ]-N, N-dimethyl-1H-1,2,4,-triazole-3-carboxamide hydrochloride dihydrate,